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Abstract.  We have identified, characterized and 
cloned a novel mammalian myosin-I motor-molecule, 
called myr 1 (m__.~osin-I from _rat). Myr 1 exists in three 
alternative splice forms: myr la, myr lb, and myr lc. 
These splice forms differ in their numbers of putative 
calmodulin/light chain binding sites.  Myr la-c were 
selectively released by ATP, bound in a  nucleotide- 
dependent manner to F-actin and exhibited amino acid 
sequences characteristic of myosin-I motor domains. 
In addition to the motor domain, they contained a 
regulatory domain with up to six putative calmodu- 
lin/light chain binding sites and a tail domain. The 
tail domain exhibited 47 % amino acid sequence iden- 
tity to the brush border myosin-I tail domain, demon- 
strating that myr 1 is related to the only other mam- 
malian myosin-I motor molecule that has been charac- 
terized so far. In contrast to brush border myosin-I 
which is expressed in mature enterocytes, myr 1 splice 
forms were differentially expressed in all tested tis- 
sues.  Therefore, myr 1 is the first mammalian myosin- 
I motor molecule with a  widespread tissue distribution 
in neonatal and adult tissues. 
The myr la splice form was preferentially expressed 
in neuronal tissues. Its expression was developmentally 
regulated during rat forebrain ontogeny and subcellu- 
lar fractionation revealed an enrichment in purified 
growth cone particles, data consistent with a  role for 
myr la in neuronal development. 
M 
YOSIN-IS differ from conventional muscle and non 
muscle myosins (myosin-I/s) by having only one 
heavy chain and a single motor domain (for review 
see 7, 24, 54).  The myosin-I motor domain is homologous 
to the motor domain of conventional myosin. This domain 
exhibits actin-activated Mg2+-ATPase activity and produces 
force along actin filaments (2,  25,  34,  64).  However,  the 
heavy  chain  of  myosin-I  molecules  lacks  the  extended 
u-helical tall domain of the conventional myosin heavy chain 
and is not capable of self-assembling into dimers and bipolar 
filaments. Instead, the tail domains of myosin-Is are thought 
to contain targeting signal(s) for membrane subdomains and 
to determine what kind of cargo is being moved. Several 
myosin-Is have been localized to specific membranous com- 
partments within cells (3,  18, 43, 66).  Therefore, myosin-I 
motor molecules were proposed to move membranes along 
actin filaments. The movements of membranes powered by 
myosin-Is may include organelle movements (1, 36) and cell 
shape changes (17). 
Myosin-Is have been first discovered in the soil amoeba 
Acanthamoeba  castellanii  (29,  31,  39,  55),  and more re- 
cently several myosin-Is have been cloned from the slime 
mold Dictyostelium  discoideum  (30,  62).  The  only well 
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characterized vertebrate myosin-I is brush border myosin-I, 
originally known as  ll0-kD calmodulin complex (10, 47). 
Associated with its heavy chain are 3-4 calmodulin mole- 
cules as light chains. Brush border myosin-I forms lateral 
links between the plasma membrane and the actin bundle 
within the microvilli of intestinal brush border cells (12, 43). 
The expression of brush  border  myosin-I is virtually re- 
stricted to intestinal brush border cells (19, 28).  Very re- 
cently, the purification of a myosin-I from bovine adrenal 
medulla and brain was reported (4). 
We hypothesized that myosin-I molecules play important 
roles in neuronal cells because actin-based cell motility is a 
fundamental prerequisite for neuronal development (46, 60). 
Functional connections between nerve cells develop through 
extensive neuronal shape changes. Furthermore, the devel- 
opment of neuritic processes  involves intense membrane 
trafficking between  neuronal  cell  bodies  and  elongating 
axons and dendrites. Shape changes and membrane traffick- 
ing are functions in which protozoan myosin-Is have been 
implicated (1, 17). Therefore, we probed the developing ner- 
vous system for the presence of myosin-I(s). 
In this communication, we report on the identification of 
a novel mammalian myosin-I  protein. To identify  mammalian 
myosin-Is expressed in the developing nervous tissue, an an- 
tibody was generated against a synthetic peptide encompass- 
ing a conserved sequence of the (invertebrate) myosin-I mo- 
tor domain which is sufficiently different from conventional 
myosin. Based on this myosin-I consensus antibody, we iden- 
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_rat), a novel myosin-I from rat tissue. We provide evidence 
that myr la-c are related to brush border myosin-I, but serve 
functions not restricted  to microvilli. Alternatively  spliced 
29 residue repeats in the regulatory domain may endow myr 
la-c with different regulatory properties. A partial and pre- 
liminary account of this work has been published in abstract 
form (B~ihler, M.,  1990. J.  Cell Biol. 111:167a). 
Materials and Methods 
Antibodies 
To raise antibodies against  a myosin-I  consensus sequence,  a  19 amino 
acid peptide  was synthesized  which duplicates  the amino acid sequence 
YLGLLENVRVRRAGYAYRQ (611-629) of bovine brush border myosin-I 
(28). A cysteine residue was added at the carboxy-terminus  of the peptide 
for the selective coupling to a carder protein. The peptide was cross-linked 
with m-maleimidobenzoyl  sulfosuccinimide  ester (MBS; Pierce Chemical 
Co.,  Rockford,  IL) to keyhole  limpet hemocyanin (Calbiochem-Behring 
Co., San Diego,  CA) as described by Green et al. (22).  Rabbits were in- 
jected  intradermally or  subcutaneously  with  300  /tg  coupled  peptide 
emulsified in complete Freunds adjuvant (Gibco Laboratories, Eggenstein, 
FRG, and Sigma Co., Deisenhofim, FRG). For booster injections,  200/~g 
coupled peptide was emulsified in incomplete Freunds adjuvant.  After two 
booster injections at 2-4 wk intervals, the rabbits were bled regularly. Pep- 
tide affinity  columns were prepared by coupling the peptide to CNBr- 
activated Sepharose  4B (Pharmacia, Freiburg,  FRG) according to the in- 
structions of the manufacturer.  Antibodies were affinity purified by passing 
the sera over the peptide column and elntion with 0.2 M glycine,  pH 2.8. 
An identical protocol was used for the generation and affinity purification 
of antibodies directed against the peptide derived myr 1 tail amino acid se- 
quence (see Results) using the synthetic peptide NKNPKYKKLKDAIEEK- 
IIIAEVVNKINC (antisera TO 2) and the myr 1 NH2-terminus  using the 
synthetic peptide MAKKEVKSSLLDNMC  (antiscra TO 30). 
A monoclonal antibody (2.17) raised against cytoplasmic myosin-II from 
A. casteUanii recognizing the motor domain (33) and a polyclonal antibody 
raised in sheep against rat GAP-43 were generous gifts of Drs. T. D. Pollard 
(Johns Hopkins Medical School, Baltimore,  MD) and L. I. Benowitz (Har- 
vard Medical  School,  Boston, MA), respectively. 
Extraction and Partial Purification of myr 1 
Extraction ofmyr 1. To test the extractability of myr La, two frozen brains 
(-70~  from 2-d old rats were thawed and homogenized in 5 rni of 0.32 M 
sucrose, 5 mM Hepes pH 7.4 with a Dounce homogenizer. The homogenate 
was centrifuged  in a TL-100 ultracentrifuge (Beckman Instruments, Palo 
Alto, CA) at 75,000 rpm for 15 rain (rotor TLA 100.2).  Pellets were re- 
suspended in 10 mM Hepes pH 7.4,  10 mM MgC12, and 100, 200, or 400 
mM NaC1, respectively. To these samples was added either 5 mM ATE 15 
mM CHAPS or nothing. One sample was extracted with 10 mM Hepes pH 
7.4, 400 mM NaC1 and 10 mM Na-pyrophosphate.  After centrifugation 
(75,000 rpm, 15 rain) supernatants were analyzed for extracted myr la by 
immunoblotting. 
To test for ATP-dependent extractability of myr lb and lc, adult rat lung 
tissue was homogenized in a Dounce homogenizer in 0.32 M sucrose, 5 mM 
Hepes  pH  7.4  and centrifuged  at  16,000  rpm in a  Sorvall  SS34  rotor 
(DuPont-Nemours,  Bad  Homburg,  FRG)  for 20  rain.  Pellets  were  re- 
suspended  in 0.1 M NaC1, 20 mM Hepes pH 7.4,  10 mM MgCI2,  1 mM 
2-mercaptoethanol, 0.1 mM EGTA and 0.1% Triton X-100 (buffer A) and 
centrifuged in a TLA-100.4 rotor at 75,000 rpm for 20 min. Pellets were 
extracted in buffer A with or without the addition of ATP (5 m_M final con- 
centration) and centrifuged  as above. Supernatants were analyzed for the 
presence of myr lb and Ic by immunoblotting. 
Partial Purification of myr la.  Approximately  340 frozen  rat brains 
(postnatal days 1-7) were homogenized in 500 ml of 0.32 M sucrose, 5 mM 
Hepes pH 7.4, and centrifuged  in a Ti60 rotor at 50000 rpm for 1 h. The 
pellet was extracted with 100 mM NaC1,  10 mM MgC12, 10 mM Hepes 
pH 7.4 and centrifuged again. The resulting pellet was extracted two more 
times with the same buffer containing 5 mM ATP. The ATP-extracts were 
loaded onto a Mono Q (HR 5/5) column (Pharmacia) preequilibrated in 20 
mM Hepes pH 7.4, 20 mM NaCI, 2 mM MgC12, 0.2 mM EDTA and 0.5 
mM 2-mercaptoethanol.  Applying a linear NaCI gradient (20 mM-1 M) 
myr fa ehited as a broad peak starting at 550 mM NaCI. Fractions contain- 
ing myr la were pooled and dialyzed against 50 mM KC1, 10 mM Hepes 
pH 7.4 and 1 mM dithiothreitol. After dialysis, the sample was loaded onto 
a 5 ml ADP-agarose column (G1BCO BRL, Eggenstein,  FRG) which had 
been preequilibrated in the dialysis buffer. The column was developed with 
a KCI gradient (50 raM-1 M) in a total volume of 40 ml, followed by a wash 
with a buffer containing 0.45 M NaCl, 20 mM Hepes pH 7.4, 50 mM KC1 
and 1 mM dithiothreitol. Finally, myr la was eluted with the wash buffer 
supplemented  with 20  mM  MgCI2 and  10  mM  ATE  Throughout the 
purification the protease inhibitors PMSF (0.1 raM) and pepstatin (2 ~tg/ml) 
were included. 
Partial  Purification of  myr lb and lc  from Rat Liver. 50 g of frozen adult 
rat liver was homogenized  in 200 ml of 0.32 M sucrose,  5 mM Hepes pH 
7.4 and centrifuged in a SS34 rotor at 18,000 rpm for 30 rain. The resulting 
pellet was extracted  with buffer B (320 mM NaCl, 20 mM Hepes pH 7.4, 
10 mM MgC12, 1 mM 2-mercaptoethanol, 0.1  mM EGTA,  and 2  mM 
NAN3) containing 0.1% Triton X-100 and was centrifuged in a Ti 50.2 rotor 
at 45,000 rpm for 1 h. The pellet was reextracted with buffer B before being 
extracted with buffer B supplemented with 5 mM ATE The ATP-extract was 
brought to 50% ammonium sulfate and the precipitate was collected, dis- 
solved in a buffer (10 rni) of 50 mM KCI, 20 mM Hepes pH 7.4,  10 mM 
MgC12, 0.1 mM EGTA,  0.5 mM 2-mercaptoethanol and 2 mM NaN3 and 
dialyzed against the same buffer to yield an actomyosin pellet. The dialysate 
was centrifuged at 75,000 rpm for 30 rain (rotor TLA 100.4).  The pellet 
was extracted  twice in buffer C (0.5 M NaC1, 20 mM Hepes pH 7.4,  10 
raM  MgC12, 0.1  mM  EGTA,  0.5  mM  2-mercaptoethanol, and 2  mM 
NAN3) supplemented with 10 mM ATP and centrifuged.  The supernatants 
were combined and concentrated in a Centricon 30 (Amicon, Beverly, MA) 
before loading onto a Superdex 200 HiLoad (16/60) gel filtration column 
(Pharmacia) equilibrated in buffer C supplemented with 2 mM ATE Frac- 
tions containing myr lb and lc were pooled and dialyzed  against low salt 
buffer  (50 mM  NaC1, 20 mM Hepes pH 7.4,  5  mM MgCI2,  0.1  mM 
EGTA,  0.5 raM 2-mereaptoethanol and 2 mM NAN3) supplemented with 
1 ram ATP followed by chromatography over a  Mono Q  (HR5/5)  ion- 
exchange column (Pharmacia) equilibrated in the low salt buffer. Myr lb 
and lc were eluted with a NaCI gradient and tested for nucleotide-dependent 
binding to F-actin.  All protein purification  procedures were performed at 
4~ 
Amino Acid Sequence Determination 
Partially purified  myr la was separated by SDS-PAGE and stained with 
Coomassie blue.  The myr  la protein band was  excised,  loaded onto a 
10-20% gradient SDS-polyacrylamide  gel and re-electrophoresed  in the 
presence of S. aureus V8 protease (6/tg) as described by Cleveland et al. 
(9).  Digested  proteins were electrophoretically  transferred to Polyvinyli- 
dene difluoride immobilon  membrane (Miilipore, Escbborn, FRG), stained 
and sequenced as described by Matsodaira (42),  using an Applied Bio- 
systems AB 470A gas-phase sequencer. 
Actin Binding 
Actin was purified from rabbit skeletal muscle as described by Pardee and 
Spudicb (51). Actin was polymerized at 1 mg/ml in a buffer of 100 mM KC1, 
2 mM MgCI2, 20 mM Hepes pH 7.4, 0.5 mM 2-mercaptoethanol and 2 
mM NAN3. Actin binding assays were performed in total volumes of 100 
#1 containing 5 #M actin. Fractions eluted from the Mono Q column en- 
riched for myr la or myr lb and lc (see above) were added to the assay mix- 
ture.  The assay buffer consisted of 20 mM Hepes pH 7.4, 2 mM MgCI2, 
0.5 mM 2-mercaptoethanol, 0.4 mM NAN3, 20 cam KCI and ,~300-350 
mM NaCl. Samples were incubated on ice for 20-30 rain. ATP (final con- 
centration 2 mM) was added from a concentrated stock solution (0.1 M) 5 
win before centrifugation.  Supernatants and pellets were obtained after cen- 
trifugation (rotor TLA 100.2) at 75,000 rpm for 20 min and analyzed for 
myr 1 protein by immunoblotting and actin by Coomassie blue staining of 
SDS-gels,  respectively. 
Tissue Preparation and Subceilular Fractionation 
Tissues were homogenized in 1% SDS,  1 mM 2-mercaptoethanol and pro- 
rein concentrations were determined by a modification  (41) of the method 
of Lowry et al. (38).  Alternatively,  they were homogenized in 0.32 M su- 
crose, 5 raM Hepes pH 7.4 and protein concentrations were determined by 
the method of Bradford (5). Aliquots of the homogenates were immediately 
placed in SDS gel sample buffer (37) and boiled. 
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K. Pfenninger (University of Colorado Health Sciences Center, Denver, 
CO) and were prepared as described (53). A crude preparation of neuronal 
and glial cell bodies was prepared according to Sbaschnig-Agler et al. (58) 
and was also a gift of Drs. Helmke and Pfenninger. 
Isolation ofa myr I cDNA-Probe by 
PCR Amplification 
First strand eDNA was  synthesized  at 42~  using  1 ~g poly(A)  + RNA 
purified from E19 embryonic rat brain tissue, superscript reverse transcrip- 
tase (GIBCO-BRL, Gaithersburg, MD) and random hexamer primers. Af- 
ter phenol/chloroform extraction and ethanol precipitation the eDNA was 
resuspended in 20 ~1 of H20 and stored at 4"C. PCR reactions in 50 #1 to- 
tal volume included 2 tzl eDNA, PCR buffer (50 mM KCl, 3 mM MgC12, 
100 #g/rnl gelatine and 10 mM Tris-HCl pH 8.3), 200/~M each of dATP, 
dGTP, dCTP, and dTTP, 25 U/ml Taq polymerase (Boehringer, Mannheim, 
FRG) and 100 pmol of the 32-fold degenerate primer MB16 (sense) 5'CAG- 
AATTCCCICA(C/T)TA(C/T)ATI(C/T)GITG(C/T)ATIAA(A/G)CC  3', 
containing an EcoRI site and the 16-fold degenerate primer MB22 (anti- 
sense) 5' TCGGATCCGGCATI(C/T)(G/A)GAT(G/A)AT(C/T)TT  3' con- 
taining a BamHI restriction site.  MBI6 was derived from the amino acid 
sequence PHYIRCIKP  and MB22 from the amino acid sequence KIFIRME 
The reaction was cycled 40 times (94~  for 1 rain, 50~  for 1 rain and 72~ 
for 1 min). The amplified  PCR products  were separated on a 4% agarose 
gel (FMC Bioproduets,  Rockland,  ME; NuSieve GTG 3:1) and fragments 
of the expected size (318 bp) were isolated and purified using Qiaex Glass- 
milk (Diagen, Hilden, FRG). The purified fragments were cloned into a dT 
tailed pBluescript SK+ vector (Stratagene Corporation, La Jolla, CA) as 
described by Marchuk et al. (40). Selected clones containing a 318 bp frag- 
ment were subjected to DNA sequencing.  The oligonucleotides  were syn- 
thesized using a Gene Assembler Plus DNA Synthesizer (Pharmacia, Mil- 
waukee,  WI). 
PCR Amplification of the myr lc Isoform 
"Ikvo PCR-primers corresponding to nucleotide 2237-2254  and nucleotide 
2843-2863 of myr la which flank the region of divergence between myr la 
and myr lb were synthesized.  Reactions were cycled 30 times (92~  for 1 
rain, 620C for 1 rain and 72~  for 1 rain) using first-strand  cDNA from 
rat kidney as template.  The obtained PCR-fragments  were cloned and se- 
quenced as described above. 
Library Screening 
A  1.2 kb cDNA clone was isolated from an embryonic (E18 rat brain) 
lambda gtl0 eDNA library (Clonetech, Palo Alto, CA) after screening with 
the myr 1 PCR fragment. This clone was used to screen a lambda Zap II 
eDNA library from adult rat brainstem/spinal cord tissue (Stratagene) and 
12 positive clones were isolated out of 2  x  106 recombinants, pBlnescript 
SK plasmids were excised from lambda ZAP II clones according to the in- 
structions of the supplier.  The clones ZgA, Z7A, Z30A, Z39A, and Z34A 
were subjected to DNA sequencing. 
DNA Sequencing 
Nucleotide sequences were determined by the method of Sanger et al. (57) 
using double-stranded DNA templates and the USB scquenase version 2.0 
kit (US Biochemicals, Cleveland, OH). For sequencing,  a series of nested 
deletions were constructed by the method of Henikoff (27) with an Erase-a- 
base kit (Promega Corp., Madison, WI). All sequences were determined 
for both strands. Nueleotide and amino acid sequences were analyzed with 
the PC/Gene (IntelliGenetics, Mountain View, CA) and the University of 
Wisconsin Genetics Computer Group (LrWGCG) (14; version 7) software 
packages.  Sequence identities and similarities were determined using the 
UWGCG program GAP. 
RNA Purification and Northern Blot Analysis 
Total RNA was prepared according to the Method of Chirgwin et al. (8) 
and poly(A)  + RNA was isolated using the PolyATract mRNA Isolation Sys- 
tem (Promega Corp.). For northern blot analysis, poly(A)  + RNA was elec- 
trophoresed in 1% agarose gels containing 2.2 M formaldehyde and trans- 
ferred  onto  Hybond-N  nylon  membranes  (Amersham,  Braunschweig, 
FRG). The filters were prehybridized and hybridized at 42~  in 50% forma- 
mide, 5x SSC, 50 mM Na-phosphate pH 7, 0.5 % SDS, 0.1 mg/ml poly(A) 
and 0.25 mg/mt denatured salmon sperm DNA. DNA probes were labeled 
using a random primer labeling kit (Boehringer). Filters were washed (2x 
SSC, 0.1% SDS at RT, 2  x  30rain, 0.1x SSC, 0.1% SDS at 650C, 10 rain) 
and exposed to X-Omat AR film (Eastman Kodak Co., Rochester, NY) at 
-70"C with a Cronex Quanta III intensifying  screen (Du Pont, Wilmington, 
DE). 
Miscellaneous Techniques 
Gel electrophoresis was performed according to Laemmli (37) and immu- 
noblotting according to Towbin et al. (63).  For immunoblotting,  primary 
antibodies were appropriately  diluted in 5% nonfat dry milk and 0.1% Tri- 
ton X-100 as blocking agents  followed by 12~I-protein A (Amersham) or 
alkaline phosphatase conjugated  secondary antibodies. Bound l~I-protein 
A was visualized by autoradiography using Kodak XAR-5  x-ray film and 
intensifying screens. Alkaline phosphatase was visualized by the ProtoBlot 
system (Promega Corp.). Calmodulin gel and blot overlays were performed 
as described by Slaughter and Means (59).  l~I-calmodulin was purchased 
from New England Nuclear (Dreieich, FRG). 
Results 
Identification of myr la with Antibodies Directed 
Against a Conserved Myosin-I Sequence 
The rabbit polyclonal antiserum G-371 raised against the 18 
amino acid synthetic peptide corresponding to amino acids 
611-629 of bovine brush border myosin-l, a well conserved 
region among the sequenced myosin-Is, reacted with three 
major proteins of neonatal rat brain on immunoblots (Fig. 
1 a). Their apparent molecular masses ranged from m90- 
130 kD. These molecular weights are well within the known 
molecular weight range of myosin-Is and above the minimal 
expected size of ,,080 kD corresponding to the size of the 
myosin motor domain. The protein with an apparent molec- 
ular mass of 130 kD was named myr la and further investi- 
gated. 
Myr la is Selectively Released by ATP 
Characteristic of myosin-I molecules is their selective ex- 
tractability  from tissue homogenates with ATP. Upon homog- 
enization of neonatal rat brain tissues, myr la protein was 
present in the soluble and in the particulate fraction and was 
only released from the particulate fraction by the addition of 
ATP (Fig. 1 b). High salt concentrations (400 mM NaCI) or 
detergent (15 mM CHAPS) were not sufficient to solubilize 
the protein.  The addition of pyrophosphate, a  compound 
which solubilizes protozoan myosin-Is efficiently (55), yielded 
a less efficient extraction of myr la. The selective extraction 
ofmyr la with ATP indicated that myr la could indeed repre- 
sent a myosin-I molecule. 
Myr la Binds in a Nucleotide-dependent Manner 
to F-Actin 
A  further characteristic of actin-based motor molecules is 
their nucleotide-dependent binding to F-actin. To test for nu- 
cleotide-dependent F-actin binding of the myr la protein, we 
partially purified the protein by ATP-extraction  and Mono Q 
ion exchange chromatography (see Materials and Methods). 
The partially purified myr la sedimented together with F-actin 
in the absence of the nucleotide ATP, but not in the pres- 
ence of ATP (Fig.  1 c), as predicted for a myosin-I motor 
molecule. 
Peptide Sequences Classify myr la as a Myosin-I 
To obtain peptide sequence information for the myr la pro- 
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characterization  of  myr la. (a) 
Immunoblot  of  neonatal  rat 
brain  homogenate with  anti- 
body G-371  directed  against 
the  myosin-I consensus pep- 
tide. The myr la band and mo- 
lecular  weight  standards  (in 
kD)  are  indicated.  (b)  ATP- 
dependent  extraction  of myr 
la from neonatal rat brain tis- 
sue.  Neonatal  rat  brain  was 
homogenized in  0.32  M  su- 
crose (H) and centrifuged to 
obtain  supernatant  (S)  and 
pellet. The pellet was extracted 
with  a  buffer  containing  10 
mM Hepes,  pH 7.4,  10 mM 
MgC12 and the indicated  con- 
centrations  of NaC1, either in 
the absence or presence (+) of 
ATP  (5  mM),  CHAPS  (15 
mM) or pyrophosphate (PPi, 
10 mM). Proteins released into 
the supernatant were separated 
on SDS-PAGE, transferred  to 
nitrocellulose and probed with 
the Tii 30 antibody.  The myr 
la  band  is  indicated  on  the 
left. (c) Nucleotide-dependent 
binding of myr la to F-actin. 
Partially purified myr la from 
rat  brain  (see  Materials  and 
Methods) was incubated in the 
absence and presence (+) of 
actin (5 #M) and ATP (2 mM), 
respectively. The F-actin bind- 
ing was assayed by cosedimen- 
tation with F-actin.  Superna- 
tants  (s) and pellets  (p) were 
analyzed  for myr  la  protein 
by  immunoblotting  with  the 
G-371 antibody. 
tein, further purification of the protein was necessary. ADP- 
agarose affinity purification and elution with ATP yielded a 
visible  protein  band on Coomassie blue  stained  SDS-gels 
(Fig. 2). The major contaminants still present in the prepara- 
tion were conventional myosin, actin and tubulin.  After gel 
purification of myr la and cleavage with S. aureus protease 
V8,  four internal peptide  sequences were derived  (see Fig. 
5).  The  peptide  sequences  AFGNAKTVRNDNSSRFGK- 
YMDIEFDFKGDPL,  FVDKNNDLLYRDLS,  and  FGR- 
SKIFIRNPRTLFQLE  revealed  a  high  homology  to  well 
conserved regions in the myosin-I motor domains. Further- 
more,  the  peptide  sequence  NKNPKYKKLKDAIEEKII- 
IAEVVNKIN exhibited a significant homology to sequences 
in the brush border myosin-I tail domain (see Fig. 7). Taken 
together, these data strongly suggested that myr la is a mem- 
ber of the myosin-I superfamily. 
Myr la Binds Calmodulin 
Brush border myosin-I has been shown to bind calmodulin 
Figure 2.  Partial  purification 
of  myr la and calmodulin bind- 
ing.  Partially  purified  myr la 
from rat brain (see Materials 
and  Methods)  was  separated 
on SDS-PAGE and stained for 
protein with Coomassie blue 
(lane 1 ); for myr la by immu- 
noblotting  with  G-371  anti- 
body (lane 2); and probed for 
calmodulin  binding  by  t25I- 
calmodulin overlay  using  0.1 
mM  CaC12 (lane  3).  Major 
contaminants  still  present  in 
the preparation were conven- 
tional  myosin  (M),  tubulin 
(T), and actin (A). Myr la and 
a presumed breakdown prod- 
uct  are  indicated  by  arrow- 
heads. 
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la was also able to bind calmodulin. Indeed, myr la did bind 
calmodulin both in the presence and absence of calcium ions 
(Fig. 2,  lane 3,  and data not shown). 
Myr la Expression is Regulated during 
Neuronal Development 
We determined the developmental expression pattern of myr 
la in rat forebrain. As shown in Fig. 3, myr la protein levels 
are regulated during rat forebrain development. The highest 
levels were found between embryonic day 17 and postnatal 
day 4 with a marked downregulation in the second week after 
birth. From there on, myr la levels stayed more or less con- 
stant during brain ontogeny. 
Myr la Is Enriched in Purified Growth Cone Particles 
To analyze the subcellular distribution of myr la in fetal rat 
brain, we probed subcellular fractions, specifically purified 
growth cone particles, for the presence of myr la (Fig. 4). 
Myr  la was significantly enriched in purified growth cone 
particles as compared to homogenate. In contrast, conven- 
tional myosin was clearly not enriched in purified growth 
cone particles (Fig. 4, lanes 1 and 5). However, GAP-43, a 
protein known to be preferentially localized in growth cones 
(21, 44) was enriched to a greater extent than myr la in puri- 
fied growth cone particles. When purified growth cone parti- 
cles were further fractionated into a cytoskeletal fraction (de- 
tergent insoluble) and a detergent extractable fraction, myr 
la  partitioned  mainly  into  the  cytoskeletal fraction,  like 
myosin and to a lesser extent also GAP-43 (Fig. 4, lanes 6 
and  7).  Myr la and GAP-43 both preferentially partitioned 
into fractions enriched in membranes (perykarya membrane 
fraction, low speed supernatant, growth cone particles) and 
they both were less enriched in a fraction rich in soluble pro- 
teins (A-fraction). This distribution was in marked contrast 
to the distribution of conventional myosin. These subcellular 
fractionation data showed that myr la was present in purified 
growth  cone  particles  and  was  possibly  associated  with 
membranes. 
Isolation and Analysis of myr I cDNA Clones Reveals 
Three Splice Forms 
We identified cDNA clones corresponding to three alterna- 
tive myr 1 splice forms, called myr la, myr lb, and myr lc. 
Clones for myr la (Z7A) and myr lb (Z9A) were isolated af- 
ter screening a cDNA library from adult rat brainstem and 
Figure 3.  Developmental expression of myr la in rat forebrain. 
Equal amounts of protein from embryonic day 17 (El7), postnatal 
days 2-51 (P2-51) and adult rat forebrain tissue homogenates were 
separated  on SDS-PAGE and transferred  to nitrocellulose.  The 
nitrocellulose was incubated with antibody Tii 30 followed  by a sec- 
ondary antibody coupled to alkaline phosphatase. 
Figure 4. Subcellular distribu- 
tion  of myr  la  in  fetal  rat 
brain.  Identical immunoblots 
were reacted with G-371 anti- 
body recognizing myr 1, anti- 
bodies  against conventional 
myosin heavy chain (2.17; my- 
osin) and GAP-43. Lanes: (1) 
homogenate;  (2)  perikarya; 
(3)  low  speed  supematant; 
(4)  A-fraction;  (5)  purified 
growth  cone  particles;  (6) 
pellet; and (7) supernatant of purified growth cone particles ex- 
tracted with 0.5% Nonidet P-40. Equal amounts of protein from 
each subcellular fraction were separated on SDS-PAGE. The ar- 
rowheads highlight the fractions of  homogenate and purified growth 
cone particles for comparison. For the method of subcellular frac- 
tionation and nomenclature of subceUular fractions see Pfenninger 
et al.  (53) and Sbaschnig-Agler et al. (58). 
spinal cord with a specific cDNA probe (see Materials and 
Methods).  Sequencing of the isolated clones revealed that 
clone Z9A contained the complete open reading frame of 
myr lb with part of the 5' and 3' noncoding sequence, and 
clone Z7A contained part  (amino acids 683-1,136)  of the 
open reading frame of myr la. The complete nucleotide and 
deduced amino acid sequences of myr la are shown in Fig. 
5. The nucleotide sequence of the PCR fragment 22/16-1 (see 
Materials and Methods), that was used for the initial library 
screening, was identical to the corresponding sequence in 
these clones (Fig. 5, arrowheads). Sequence information of 
the third splice form, myr lc, was obtained after PCR ampli- 
fication of  rat kidney cDNA with myr 1 specific primers. The 
open reading frame of myr la-c started with an initiation se- 
quence that was similar to the consensus initiation sequence 
described by Kozak (35).  Nucleotide sequences of the iso- 
lated myr 1 clones were identical, except for a short region 
of diversity between myr la-c. The deduced amino acid se- 
quences of the myr 1 splice forms differed at amino acid 795 
in that myr la contained three imperfect repeats of 29 amino 
acids, myr lb two imperfect repeats of 29 amino acids and 
myr lc a single copy of the 29 amino acid motif (Fig. 6). In 
good agreement with the molecular masses determined by 
SDS-gels (130 kD for myr la), the calculated masses from 
the deduced amino acid sequences were 131,917 D for myr 
la (1,136 amino acids),  128,428 D for myr lb (1,107 amino 
acids) and 124,870 D for myr lc (1,078 amino acids), respec- 
tively. The isolated cDNA clones were encoding the four 
peptide sequences determined by direct amino acid sequenc- 
ing of purified myr 1 protein (underlined amino acids in Fig. 
5). These data demonstrated that the isolated cDNA clones 
were indeed encoding myr 1. Furthermore, the peptide se- 
quence corresponding to the region recognized by the poly- 
clonal antiserum G-371 was identified at position 618-636 of 
myr la-c (double underlined, Fig. 5). 
Sequence Analysis and Structural Organization 
of myr 1 
Analysis of  the deduced myr lc amino acid sequence revealed 
an amino-terminal motor domain (amino acids 1-705), a reg- 
ulatory domain with putative calmodulin/light chain binding 
Ruppert et al. Mammalian  Myosin-I  1397 1  GT  CGGCT  GAGCGGCGCCGGATCCCTGGCAAAACTGTGGCACGAA•CCCGCATCGGGTCGGA•CCGCGTTCCCCAGGCGCCGGCCAGCGAGCAGCACGCGAGGCGAGCGGCAGAGCGGTTG 
121  CCGGGCGAGCTGGAAACCATGGCCAAGAAGGAGGTAAAATCCTCACTTCTGGACAATATGATCGGCGTTGGA•ATACGGTTC  TCTTGGAGCCTCTCAACGAGGAGACGTTCATCGACAAC 
A  K  K  E  V  K  S  S  L  D  N  M  I  G  V  D  T  L  L  P  L  N  E  T  I  D  N 
241  CTGAAGAAGCGCT TCGATCACAATGAGATATATACATACATCGGGAGTGTGGTTATATCT•TTAACCCCTACCGGTCCTTGCCCATTTATTCA•CAGAGAAAGTGGAAGATTACAGAAAT 
L  K  K  F  D  N  E  I  Y  T  Y  G  S  V  I  S  V  N  P  R  S  P  I  S  P  E  V  E  Y  R  B 
361  AGA~ACTTCTATGAACTGAGCCCTCACATCTTTGCT  TTGTCGGATGAAGCATACAGATCCCTCCGTGATCAAGATAAAGATCAGTGCATTCTCATTACTGGGGAGAGTGGAGCGGGAAAA 
R  N  F  E  L  P  H  I  F  A  L  D  E  Y  R  L  R  D  D  K  Q  C  L  I  T  E  S  A  G  K 
481  ACAGAGGCCAGCAAGCTTGTGATGTCC  TATGTCGCTGCAGTGTGTGGAAAAGGAGCAGAAGTTAATCAGGTCAAGGAACAGCTTC  TCCAGTC  CACCCCTGTCCTGGAAGCTTTTGGAAAT 
T  E  A  K  L  M  S  Y  V  A  A  C  G  C  A  V  N  O  K  E  O  L  L  S  T  P  L  E  F  G  N 
601  GCCAAGACTGTAAGGAATGACAATTCATC~AGATTCGGC~%ATACATGGATATTGA2tTTT~4%CTTT~b%AGGCGATC~GCTGGGAGGAGTGATAAGTAACTATCTTTTAGA~TCTCGT 
A  K  T  R  N  N  S  S  R  F  G  Y  M  I  E  D  F  K  D  P  L  G  G  I  S  N  L  L  [(  S  R 
721  GTTGTTAAGCAGCCGAGAGGTGAAAGAAACTTcCACGTGTTCTATCAGCTGCTCTCG~GTGCCTCTGAGGAACTCCTCCACAAGCTTAAAC  TGGAGCGGGATTTCAGCAGATACAACTAT 
V  V  K  P  R  E  R  N  F  H  V  Y  Q  L  S  A  S  E  L  L  K  L  L  E  R  F  S  Y  N  Y 
841  C  TGAGTCTGGACTCTGCCAAAGTGAATGGTGTGGACGAC  G  C  T  GCCAATTTCAGAACTGTCAGGAATGCCATGCAGATCGTGGGCTT  T  TCGGATCC T  GAGGCCGAGTCTGTCCTGGAGGTT 
L  S  L  S  A  V  N  G  V  D  D  A  N  R  T  V  R  N  A  M  Q  I  G  F  D  P  E  E  S  L  E  V 
961  GTGGCAGCTGTCTTGAAACTGGGGAAcATCGAGTTCAAGCCTGAATCACGAATGAACGGTTTGGATGA~GCA~TCA~AGACAAAAATGAGTTAAAAGAAATTTGTGAGTTGACCAGC 
V  A  A  L  K  G  N  I  E  F  K  E  S  M  N  L  D  E  K  I  D  K  E  L  K  I  C  L  T 
1081  ATCGATCAAGTGGTTTTAGAAAGAGCGTTCAGTTTCCGAACGGTTGAGGCGAAGCAGGAGAAAGTTT~ACCACATTGAATGTGGCTCAGGCTTATTATGCCCGTGATGC~CTGGCTA~ 
I  D  O  V  L  R  A  F  S  F  R  V  E  K  O  E  K  V  $  T  T  L  V  A  A  Y  u  R  O  L  A 
1201  ILAC  C  T  C  TACAG  C  C  G  GT  T  G  T  T  T  T  C  ATG  GT  T  GG  TJL~.~T  C  GA.~T  CAAC  G  J~AGCAT  T/tAGGCACAAAC CJLrtAGT  GAGJtA~t  G  JL~G  G  T  CAT  G  GG  T  G  T  T  C  T  G  GACATT  TATG  G  C  TT  T  C,  AGATATT  T 
N  L  Y  R  L  S  W  L  V  N  R  N  S  I  K  A  Q  T  K  V  R  K  V  M  V  L  D  I  Y  G  E  I  F 
1321  GAGGACAACAGCTTCGAGCAGTT  CATTATTAATTATTGTAATGA~GCTTCAACAAATCTTCATTGAACTGACCCTCAAAGAAGAGCAAGAGGAATATATTCGTGAGGACATAGAATGG 
E  D  N  F  E  F  I  I  N  Y  C  E  K  O  O  F  I  E  L  T  L  E  E  E  E  Y  I  R  E  I  E 
1441  ACT  CACATTGACTACTTCAACAATGCTATCATTTGcGACCTAATAGAAAACAACACAAACGGAATCTTGGCCATGCTGGATGAAGAGTGCCTGAGACCCGGCACTGTTACAGATGAGACC 
T  H  I  Y  F  N  A  I  C  D  I  E  N  T  N  G  I  L  A  M  L  E  E  L  R  P  G  T  V  D  E  T 
]561  T•CCTGGAAA•GCTGAACCAAGTCTGTG•CACCCACCAGCACTTCGAGAGCAGGATGAGCAAATGTTCCCGCTTCCTCAATGACACGACCCTGCCTCA•AGCTG•TTCAGA•TCCAGCAT 
F  L  E  L  N  V  C  T  H  O  F  E  R  M  K  C  S  F  L  D  T  L  P  H  C  F  I  Q 
1681  TATGCTGGCAAGGT GCTATACCAGGTGGAAGGGT  TTGTTGACAAGAACAATGACCTTCTGTAC  CGAGACCTGTCTCAAGCCATGTGGAAGGCTGGCCATGCCCTCATCAAGTCTCTGTTC 
Y  A  G  V  L  Q  V  G  F  V  K  N  D  L  L  Y  R  D  L  $  Q  M  g  A  G  H  L  I  S  L 
>>> 
1801  C  CTGAAGGGAATC C  TGCAAAGGTCAACCTGAAAAGACCTCCTACTGCAGGGTCCCAGTTCAAGGCGTCGGTGGCCACCC  T  GATG~CCTGCAGAC  CAAGAAC  C  C  C~C TATATCAGG 
P  E  G  P  A  V  N  K  R  P  T  A  S  Q  K  A  S  V  A  T  M  K  L  Q  T  N  P  N  Y  I 
1921  TGCATCAAGCCGA•CGATAAAAAGGCCGCTCACATTTTCAGTGAGAGTCTCGTGTGCCATCAGATCCGGTACCTGGGTCTTCTGGAGAACGTTCGAGTGAGACGGGCAGGCT•TG••TTC 
C  I  K  U  D  K  A  H  I  F  E  S  V  C  Q  I  R  L  G  L  E  V  R  V  R  A  G  u  A 
2041  AGGCAGGCCTATGAACCTTGTCTGGAAAGATACAAGATGCT  TTGC/~CA~CATGGCCTCACTGGAAGGGACCAGCAAGGTCTGGTGTGG/tAGTT  CTGTTTAATGAGCTAGAGATTCCC 
R  Q  A  E  P  L  E  Y  K  M  C  K  Q  T  •  P  H  W  K  P  A  S  G  E  V  L  N  E  E  I  P 
<<<  . 
2161  GTGG~tAGAGTACTCCTTCGGTAGAT~C$~AGATATT~ATCCG~%~CCCAAGGA~ATTATTcCA~TTAGAAGACCTAAGGAAGCAGCGGCTGGAGGA~  TGGCCACTCTCATTCAG~GATT 
V  E  E  S  F  R  S  I  F  I  N  P  R  T  L  F  Q  L  E  L  R  O  R  E  D  L  T  L  Q  K 
2281  TATCGAGGATGGAAATGTCGTACACATTTTCTGCTCATGAA~C~GCCAAGTCGTGATTGCCGCC  TGGTACAGGAGATACGCGCAACAAAAGCGATATCAGCAGATAAAGAGTTCAGCC 
Y  R  G  K  C  T  H  L  L  M  R  S  O  v  V  A  A  W  a  a  A  Q  K  R  Y  O  I  S  S  A 
2401  CTGGTGATTCAGTCT TACATCCGGGGCTGGAAGGCTAG~TCCTGCGGGAGCTGAAGCATCAGAAAC  GCTGCAAGGAGGCAGCCACCACCATCGCAGCATACTGGCACGGCACCCAG 
L  V  I  S  Y  R  G  W  K  A  R  I  L  E  L  H  Q  K  C  K  A  A  T  I  A  Y  W  O  T 
2521  GCGCGAAAGGAGCGGAGGCGGCTGAAGGACGAGGCTAGGAATAAGCACGCTATT  GCAGTTATTTGGGCTTTCTGGCTTGGATCGAAGGCACGAAGGGAATTGAAACGCTTGAAGGAGGAG 
A  R  K  R  R  L  K  D  E  A  a  K  H  A  I  A  I  W  A  W  L  $  K  A  R  R  E  K  R  K  E 
2641  GCTAGGCGTAAGCATGCAGTTGCTGTCATTTGGGCTTACTGGCTTGGACTG~GGTACGIL%GGGAGTACAGGA~TT  CTTTAGAGCAAATGCTGGAJ~gGA.~TCTATGAGTTTACACTT 
A  R  R  H  A  A  V  W  A  Y  L  S  L  K  V  R  E  u  K  F  R  A  N  A  G  K  I  Y  F  T 
2761  C~AGAATTGTGCAAAAATACTTGTTGG~TGAA/~%T'tu~ATGCCTTCCTTGTCACCAATAGATAAAA.%TTGGCCATCAAGACC  TTACCTATTCTTGGATTCGACTCACAAGGAGCTA 
Q  R  I  Q  K  L  L  E  M  K  N  M  P  S  L  S  I  D  K  W  P  R  P  Y  L  F  L  S  T  K  E 
2881  AAAAGGATCTTCCAC TTGTGGAGGTGTAI~TACAGGGATCAATTCACAGACCAGCAGJLAACTTATTTATGAAGAGAAGCT  GGAGGCCAGTGAACTCTTCAAAGACAAGAAGGCTTTA 
K  R  I  H  L  R  C  K  W  R  O  F  T  D  O  K  L  I  E  E  L  E  A  $  E  L  K  D  K  A 
3001  TAT  CC  TTC  TAGTGTT  GGTCAGCCATTCCAAGGAGCTTACCTGGAAATCAACAAGAACCCAAAATATAAGAAACTCAAAGATGCCAT  TGAAGAGAAGATCATTATTGCTGAGGTTGTGAAC 
Y  P  s  v  G  Q  P  F  Q  G  A  Y  L  E  I  N  K  N  P  I(  Y  K  L  K  A  I  E  E  K  I  I  I  A  V  V 
3121  ~TCAAC  C  GGGCTAATGGGAAGAGTACATCTCGGATTT  T  CC  T  CTTAACAAACAATAACCTTC  T  CCTTGCTGACCA~GTCGGGGCAGATCAAGTCCGAGGT  C  CCC  C  TGGTGGATGT G 
K  I  N  A  N  K  S  S  R  I  F  L  L  T  N  N  N  L  L  L  D  Q  S  G  O  I  [~  $  E  %'  P  V  D 
3241  ACTAAGGTCTCCAT GAG  TT  CACAGAATGATGGTTTCTTTGCAGTACACCTCAAGGAGGGTTCAG;L%GCAGCTAGTAAGGGTGACT  T  TCTCT  T  CAGCAGTGACCACCTGATTGAAATGGCA 
T  K  V  M  S  O  N  a  F  F  A  V  H  L  K  E  G  S  K  A  $  K  O  F  L  F  S  S  D  H  L  I  E  M 
3361  ACCAAGT  TGTATCGCACGACTC TTAGC  C;Lt-AC  TAAACAGAAGCT CAATATCGAGATT TC  CGATGAGTTCCTGGTACAGTTCAGACAGGACAAAGTATGTGTGAAGTTTATTCAAGGCAAC 
T  K  L  R  T  T  L  S  T  K  Q  K  L  N  I  E  I  S  D  E  F  V  Q  R  Q  D  K  %"  C  V  K  F  I  Q  G 
3481  C  AGA~CGGGAGCGTGCCAACCTGCA~CGAAAGAACAACAGGCTTC  T  TGAAGTC  G  CTGTCCCTTAAGT GAGGCCTCC T  CTCTGTTC T  CACGGACTTGTT T  CCTCGTAACAGTGCAAT 






























Figure 5.  Nucleotide and de- 
duced  amino acid  sequences 
of  the  myr  la  cDNA.  The 
amino acid sequence ofmyr la 
is shown below the nucleotide 
sequence.  The start codon at 
positions  139-141  is  under- 
lined.  Peptide  sequences de- 
termined by direct amino acid 
sequencing  after  cleavage  of 
purified  myr  1  protein  with 
S. aureus pmtease as described 
in Materials and Methods are 
underlined. The double under- 
lined  peptide  sequence  indi- 
cates the corresponding region 
recognized by the polyclonal 
antiserum G-371. Arrowheads 
above the nucleotide sequence 
mark the  ends  of the  PeR- 
generated  fragment  used  for 
the  initial  library  screening. 
The nucleotide  sequence data 
are accessible through EMBL, 
GenBank,  and DDBJ nucleo- 
tide sequence databases under 
the accession number X68199. 
sites (amino acids 706-794)  and a carboxy-terminal tail do- 
main (amino acids  795-1078). 
The Motor Domain.  The amino-terminal  motor domain 
exhibited a consensus ATP-binding site and sequences which 
are thought to be important  for actin binding  (Fig.  7).  A 
comparison of the myr 1 motor domain sequence with that 
of bovine brush border myosin-I indicated that these two do- 
mains are highly homologous (66%  identity,  78 % similar- 
ity).  With the exception of seven additional  amino acids  at 
the very amino terminus of myr 1, the two sequences were 
aligned  without the introduction of gaps. 
The Regulatory  Domain.  The  regulatory  domain  con- 
sisted of multiple repeats of putative calmodulin/light chain 
binding motifs (Fig.  8).  Myr la-c contained up to six con- 
myr  la 
myr  ib 
myr  ic 
791  HGTQARKERR RLKDEARNKH AIAVIWAFWL GSKARRELKR LKEEARRKHAVAVIWAYWLG  LKVRREYRKF  860 
791  HGTQ .............................  ARRELKRLKE~VAVZWAYWLG  LKVRREYRKF  831 
791  HGTQ ..........................................................  VRREYRKF  802 
Figure 6. Identification of alternative spliceforms  of myr 1. Three alternative splice forms of myr 1, myr la-c were identified.  Alignment 
of the deduced myr 1 amino acid sequences revealed that myr lb exhibits a deletion of 29 amino acids and myr lca deletion of 2  x  29 
amino acids  as compared  to myr la. 
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BA  M'~L LEGS  V~VEDL 
C  MAM~VI($$L  LDNM  I  GV~DT 
.........  L  L  ....  GV.D. 
51 
A  VVIS%rNPYKP  LPIYTPEMME 
B  VLVSVNPY~  LP  IYDLEFVA 
C  Wl SVNPYRS  LP  IYSPEMVE 
VvlSVNPF.. L~fY￿9 
101  ATP 
A  DQC  IL  ITG/E---~  ~I*EAS  I(L 
B  DQC  ILIT~I~II ~I~AS  IC~ 
C  DQC  IL  IT&~S ~I~ 
DQCI~ITGES GA~ATEASKL 
151 
A  AFGNAK'~  I  RN DN  $S  RI~GKYM 
CB  AFGNAKT  !~N 
AF~NARTVRN 
AFGNAKTIRN 
A  CEItNFH  I  ryO 
B  GERNFRI~YQ 
C  GERNF  HIrFYQ 
GERNFHI  FZQ 
251 
A  FRAMQDAMA I 
B  FKVLOSAMTV 
C  FRTVRNAMQ  I 
Ft..  q  .AM~  1 
301 
A  AEPRELQEIS 
B  RDGRGVQEIC 
C  KDKNELKEIC 
￿9  d*  relqEI  * 
351 
A  ALAMN  IYSRL 
B  ALA/(N I  YSRL 
C  ALAKNLYSRL 
ALAKN~YSRL 
401 
A  QFI  IN  YCNE}( 
B  QFVINYCNEK 
C  QFI  INYCNEK 
QFI  INYCNKK 
451 
A  N  Sk~ I  LAML 
ONQRGILAML 
C  NNTNGILAML 
on..GILAML 
50~ 
A  TDVSLPLRCF 
B  YDESMGLSCF 
C  NDTTLPII$CF 
~ 
551 
A  RSLFPEGDPQ 
B  RSLFPEGDPK 
C  KSLFP~NPA 
FSLFPgGd2. 
601 
A  T  I(TAMLFTP  D 
B  HQQRGKFSFE 
C  KMAAH  IFSES 
.k.~.  ￿9  . 
65~ 
A  KTWPRWTC4~D 
B  STWPRWNGGD 
C  QTWP  )IWI(GPA 
￿9  TW~rW.  Ggd 
701 
A  Q~VAELATL 
B  RLRLQ~LATL 
C  RQRLEDLATL 
￿9  q~  1  ￿9 ~ATL 
751 
BA  KRSVLLL~AY 
KASALLI~AF 
C  KSSALVI~Y 
K.Sa~llQay 
801 
BAR YF  R$  DACe2  R 
KYFRSGAALI 
C  KF~RANACKK 
kyFas.A... 
~51 
A  DAN~LMSIF 
B  TANHELQRLF 
C  STHKELKRIF 
.an .~LkriF 
901 
A  LQ~PF  RGEYL 
B  VP  I  PF~GDY  I 
C  VC~PF~AYL 
v  ￿9  qPF.  G.  Y1 
951 
BA  LLTTEflLVLA 
LLTIeGHV  I  IT 
C  LLTWNNLLLA 
LLT.*hl.la 
1001 
A  CI(GDLLLVSP 




A  TVV/ISAXC4~G 
KVI  ~GPGGGG 




VLLEPLEQES  LIRNLQLRYE  KKEIYTYIGN 
VLLEPLNEET  FIDNLKK~PD  HNEIYTYIG$ 
VLLEPL..E..I.ML..R ....  E~YTMIG. 
100 
EYIINCNFFAV ~HIYAIId~D  AYRSLRDRDR 
KYRDYTFYEL  KPHIYAId~  AYQSLRDRDR 
DYRNRNFYEL  SPHIFALSDE  AYRSLRD(~K 
.Yrn.nFyw2 kPMlyAlad. AFFSLRDFDr 
150 
VMS~AAV~S  }(GEEVDI~  QLLQSNPVIE 
9MSYVAAVCC  KGEQVNS%,~  QLLQSNP%'LE 
%940YVAA~G  KGAEVNQ~  QLL(~STPI~E 
V~IS~AAVcg KGeeVn.VKE  OLLQSnPVLE 
200 
DVEFDFKGDP  LG~'ISNYLL  EKSRIVRH%q4 
NNSSRFGI(YM  DIEFDFKCFP  LGGVITNYLL  EKSRICCI(QLE 
DN$SRFGKYM  DIEFDFKGDP  LC-GVISWYLL  EKSRVVMQgR 
dNSSRFGK~4 DIEFOFKGdP LGGVISNYLL EKSRvVkq.. 
250 
~LLAGGSA~LL  ~}fLRPDCS  HyGyLNEdZR$  VI~GMDDAP~ 
LLACADAQLL  KALKLERD'i'G  GYAYLNPDT$  RVDG~DDDAN 
LLSGASEELL  HIfLI~ZRDFS  RYNYLSLDSA  M'V'NGVDDAAW 
LLaGasaqLL ..  LFJ~eED  .  8  .  Y.  YL~  .  d. s  .  v.  GmDDaAll 
3O0 
IGFAPAEVTA LLEV~AVVIK  LGNVKLSSSF  OAS~MEASSI 
IGFSDEEIRQ  VLE%rAALV~K LGN%rELINEF Q/%N~ASGI 
VGFSDPKAES  %'LEWAAVLK  LCNIEF~ES  ~'~/GLDESKI 
IGFsd.E.  .  . vLEV.A.  VLK LGNvel  .  .el qanG.  .~S. I 
350 
QLICLDPSTL  E(I/~LCSRT%rK VROESVLT~L  5VSQGYYGRD 
ELVGI~$VEL  ERALCSRTME  TAKEK%n}TTL  NVIQAQYARD 
ELTSID~/VL  ERAFSFRTVE  AKQEI~/STTL NVAQAYYi%~D 
eL.gld.v.L ErAlcsRTve  ...EkV.TtL nV.QayYaRD 
400 
FDWLVNRINT  SrQVKPGI(QR  K'VMGV~DIYG  FEIFQDNGFE 
F~M'~VNRINE  SIK'4GTGEKR  I(V/4GVLDIYG  FEILEDNSFE 
FSWLVNRINE  $11(AQTIfg"RK If~VLDIYG  FEIFEDNSFE 
F.WLVNRINe $~kv.~g..r Kg?4GVLDI~G FEIfeDWsFE 
450 
L~FILMTL  KEEQEEYVRE  AI~TP~EPF  DN$IICDLIE 
L~IEMTL  gEEQEEY~RE  GIPMVI~F  DNGIICNLIE 
IA2~IFIELTL  MEEQEEYIRE  DIE~THIDYF  NNAIICDLIE 
L~QiFIemTL KEEQ~EY.RE .  I.  W~.  veyF dN.  IICdLIE 
500 
DEECLRPGTV  NEDTFIT~N  QIFASHKRME  $~TLNAY~V 
DEE/2LRPGW  SDSTFLAKLN  OLFSKaSBYE  SI~NAQRQ 
DEECLRPGTV  TDETFLEKLN  QVCATHQHFE  SRMSKCSRFL 
DEECLRPGt  V  .  d.  TFI.  KLN O.  fa.  H.  hys Sk.  t.  na... 
ACTIN  550 
RIHII~  YII~IEI~II  WDDI~LSQ  AMWAARHTLL 
RICI~  ~'R%~II~  IIDI,  LI~DLZQ  AMWKARHPLL 
RI~IE~  Y(~II~  I~I~5%ItDLSQ  AMWKAGHALI 
RI.HZAGKVt  ~nV.gFIdKN NDLLfROLSQ AMWkArH.LI 
ACTIN 
ItgSLKLPPTT  GSQFKASVIT  ~m~l~  IITII~KK~IID 
QASLMRPPTA  CAQ~'I(S$%"ET LI~'I~  IITI~IIK~ 
K~LI(RPPTA  GSQFKASV~kT I~41~IX4~T~  WTZ~II~D 
￿9  .sLKrRPTa GsOFKaBVaT LM~LMsKNP  NZIRCIKPNd 
650 
LVLAQVRYLG  LMENVRVRRA  GYAFRQLYQP  FLERY~4LSR 
LVSVQAQYLG  LLENVT~VRRA GYAYRQAYGS  FLERYRLLSR 
LVCHQIRYLG  LLENVRVRRA  GYAFRQAYEp  CLERY~LCK 
LV..Q.rZLG LIKNVRVRRA GZAfRQaY.p fLERykmLsr 
700 
KEGAZVLLAE  LKFPPEELAY  GBTKIFIR$~*  RTLFDLEKRR 
QECVEXVLGE  LSMSSEELAF  GI(T/(IFIRSP  KTLFYLEEQR 
RSGg"EVLFNE  LEIPIrEEYSF GRSKIFIRNP  RTLFQLEDLR 
reGvEv]l.E L,.p.EElaf G.  tKIFIRsP rTLF.  LE..R 
750 
IQRMFRGMCC  RKRYQLMR2KS  OILISAI4FRG  I~RNRYKQM 
IQKTYRGI~RC  RTHYQLMRKS  QIVISS~FRG  NM~RIKHYR~M 
IQKI~R~WMC  RTHI~LLMI(I~S Q~IAA~I~R  YA~KRYQQI 
[QK.yRf~W.C RthyqLMrkS QlvfsaWfRg .mQ.krY.qm 
800 
ARCWK  .............................  TF~tMYR 
VRG~K  .............................  ARIC~YR 
IRG~KARKIL  RELRH~I(RCM EAATTIAAYW  RGTQWRREYR 
.RGWK  ..............................  RFoYR 
85O 
LSN?IYRRM~  QK'Y~MGL~  LPPMAVLDRT  WPPAPYKFL$ 
LSNFIYKSMV  Qi~2FLLGL~D  LPSP$ILDKI( MpSAPYKYFN 
IYEFTLQ2tlV QMYLLEMI~M MPSLSPIDRN  MPSRgYLFLD 
ISnFIy.~V  OKyLlglkn.  iPs.s.iDk. WPsa~Ykfl. 
900 
YRI4"KCKKYRE  QLTl~Q~/~AML  (~%Ir  RDKKALYAQO 
HQWKCKI(FRD QLSPKQVE~FL RE/(~CAOELF MGKKASYPQO 
EuLWRCKK~I~D  QFTD~LIY  EEIC~KASELF KDMKALYP$O 
h.W~CKKyRd ~it~qQ...  i  .eF~5.aseLF KdKKAIYpqS 
950 
GLTQNRMYQR  LQA%OKI(D/(IV MAEAVQK%rMR AMGKTV?RLL 
GLQRNPIfLQK LKG~EEGPIL  MAETVVI~R  GI4AJ(TSSRIL 
EINKWPI(YICK  LMDAIEEKII  IAEV~KINR  #d~GKSTSRIF 
gl.  *NpKyqK Lk...e.kl. mAE.  V.  KVNR aWgKt.sRil 
1000 
DPI(A~?~  LSLCDIQGAS  VSRFSDCLLA  LIILK~TSTAG 
DMMNPQAKTM  IPLNSLAGVS  VTSFI(DGLFS  LIILSEI$$VG 
D~M$C~IMSE  VPL%?DVTKV$  MS$~NDGFFA  VILL~GSEAA 
D.K*.Q.K.v .pL.d..gv$ VSsf.  DGIf~ IHLkE.S.ag 
1050 
KLIELVTRLII QTLMDATAQA  LPL$1ADQFS  TRFPI(GDVAV 
HVIELLTKIC  RATLDATQMQ  LPVTVTEEF$  V/(I~I(]gGSLTV 
HLIEMATMLY  RTTLSQTKQK  LNIEISDEFL  VQFRQDIfVCV 
HIIEI.TkI*  rt~ldaT,q, Lp..i.deFs v.F..g.v.v 
DVPVC--  K~Rf~ $ I~JO~E  I L%,R 
TG~ SFI(XKG  S  RCLEVTVQ 
SVPTC-  l~t](N N  RLLEVAVP 
.vp.c.F~Kgsr.l~v.v. 
secutive repeats (amino acids 706-867) of the IQ-motif as 
defined by Cheney and Mooseker (7) (Fig.  8 A). This motif 
has been shown to be responsible for the Ca2+-independent 
calmodulin binding of the nonmyosin protein neuromodulin 
(6). Three consecutive repeats of this IQ-motif had previ- 
ously been identified in brush border myosin-I (7, 61). These 
three brush border myosin-I repeats  shared an identity  of 
60%  (80% similarity)  with the first three repeats in myr 1. 
As in brush border myosin-I, the second repeat in myr I was 
the least similar to the IQ-consensus sequence. 
Partially  overlapping  with  the  sequence  (amino  acids 
766-774) of the third IQ-motif repeat, the myr 1 regulatory 
domain contained variable numbers of imperfect 29 residue 
repeats. These repeats were also fitted into the IQ-motif (Fig. 
8 A). However, the relation of these repeats to the IQ-motif 
seemed uncertain, because highly conserved residues of the 
IQ-motif, like the glutamine (Q) residue and the arginine (R) 
residue following three residues  after the conserved gluta- 
mine residue were not conserved in these repeats. These 29 
residue repeats were present in one constitutive  and two al- 
ternatively spliced variants. Individual pairwise comparison 
of these amino acid repeats revealed 72 % identity between 
the  two  facultative  29  amino  acid  repeats  (amino  acids 
795-823 and 824-852) and '~41% between the constitutive 
(amino acids 766-794) and each of the two facultative  29 
amino acid repeats. A 29 amino acid alternative splice insert 
with a similar sequence (55 % identity to the constitutive myr 
1 repeat) has been reported for a low abundance isoform of 
chicken brush border myosin-I (23) (Fig. 8 B).  All four of 
these 29 amino acid repeats fit the motif with the consen- 
sus sequence XRBXXBXL  *WXGXX 
(B, basic residue;  #, hydrophobic residue;  *  aromatic resi- 
due) (Fig.  8 B).  A  synthetic peptide  corresponding  to the 
chicken  brush border myosin-I alternative splice insert se- 
quence  has been  demonstrated  to bind  calmodulin  (23). 
Therefore,  the 29 amino acid repeats  found in myr 1 are 
likely to be involved in calmodulin/light chain binding. The 
three alternative splice forms of myr 1 differed in their num- 
bers of 29 amino acid repeats. In total, myr la contained six, 
myr lb five and myr lc four putative calmodulin/light chain 
binding sites. 
The Tail Domain.  The carboxy-terminal  tail domain of 
myr la (~-,33 kD) which followed the variable regulatory do- 
main was identical in all three splice forms. Like the tail do- 
mains of other myosin-I molecules, the myr 1 tail domain ex- 
hibited  a high number of basic residues (,',,20%).  Specific 
functions of myosin-I molecules were thought to depend on 
their individual tail domains. Therefore, it was of particular 
interest that the tail domain of myr 1 shared significant ho- 
mology with the tail domain of bovine brush border myosin- 
I. In this carboxy-terminal domain, 46% of the amino acids 
Figure Z Alignment of avian brush border myosin-I (19) (A), bo- 
vine brush border myosin-I (28) (B) and myr lc (C) heavy chains. 
The derived consensus sequence is shown below the aligned se- 
quences. Amino acids that are identical in all three sequences are 
indicated  in capital letters and amino acids identical in two of the 
three sequences in lower case letters. ATP and putative actin bind- 
ing sites in the motor domain are indicated. 






DLATLIQKIY RGWKCRTHFL LMK 
RSQVVIAAWY RRYAQQKRYQ QIK 
SSALVIQSYI ~WKARKILR  ELKHQKRCK 
EAATTIAAYW HGTQARKERR RLKDEARNK 
HAIAVIWAFW LGSKARRELKRLKEEARRK 




myr  la  766 
SRRLLRELKV QRRRHI2&AST ISAYWKGYQ 
/%RKILRELKH QKRCKEAATT IAAYWHGTQ 
ARKERR/~LKD EARNKHAIAV I~LGSK 
ARRELKRLKE E~VAV  IWA~WWLGLK 




Figure 8.  Putative  calmodulin/light  chain  binding  sites  in  the 
regulatory domain ofmyr 1. (A) Alignment of  the IQ-motifs present 
in myr la (amino acids 706-867) with the calmodulin binding se- 
quence of neuromodulin (bold) (6). The three imperfect 29 residue 
repeats with homology to the chicken brush border splice insert are 
underlined.  Conserved amino acids are printed in bold type.  (B) 
Alignment  of the three  myr la 29 residue  repeats  (amino  acids 
766-852)  with the 29 residue chicken brush border myosin-I alter- 
native splice insert (23). The derived 29 residue motif consensus 
sequence  is shown below the alignment.  Capital  letters  indicate 
conserved residues,  +  indicate conserved basic residues,  * con- 
served aromatic  residues, and # conserved hydrophobic residues. 
Conserved amino acids are printed  in bold type. 
were identical (67 % were similar with the introduction of a 
single gap of one residue) with the analogous domain in bo- 
vine brush border myosin-I. This homology was lower as 
compared to the homologies found in the motor domain and 
the overlapping regions of the regulatory domain, but clearly 
indicated that myr 1 and brush border myosin-I are related 
proteins. 
Expression of  myr I mRNA in Various 7issues 
Northern blot analysis of poly(A)  + RNA from adult (Fig. 9 
A) and neonatal (Fig. 9 B) rat tissues revealed that myr 1 was 
expressed in most of the investigated tissues. A broad band 
with  an  apparent  size  range  of 5.7-6.2  kb  was  strongly 
labeled in adult lung, but was barely detectable in adult intes- 
tine.  Expression of myr 1 was detected in all of the inves- 
tigated  neonatal  tissues.  Remarkably high  levels  of tran- 
scripts were observed in neonatal brain and lung tissues. In 
striking contrast to the preferential expression of brush bor- 
der myosin-I in intestine  (19, 32),  northern blot data indi- 
cated a widespread tissue distribution of myr 1. A faint band 
of unknown origin below the main band was also detected. 
Differential Expression of  myr I a-c 
In agreement with the identification of three myr 1 splice 
forms by cDNA cloning, we detected three closely spaced 
protein bands upon immunoblotting with myr 1 specific anti- 
bodies (Fig.  10).  Several antisera specific for myr 1 were 
raised (see Materials and Methods and unpublished results). 
All of these antisera recognized strongly the identical  130- 
kD protein band in embryonic rat brain originally identified 
by the consensus myosin-I antibody G-371. The 130-kD pro- 
tein band was the slowest migrating band observed in any tis- 
sue.  Because the apparent molecular mass coincided with 
the deduced  molecular weight of myr la,  we refer to this 
band as myr la. In adult brain regions we observed an addi- 
tional band running slightly ahead of  myr la with an apparent 
molecular mass expected for myr lb. The detection of myr 
la and myr lb in brainstem (Fig.  10) is in excellent agree- 
ment with the cloning of myr la and myr lb out of a brain- 
stem cDNA library. A third, again slightly faster migrating 
immunostained protein band was apparent in many tissues 
but was most prominent in lung tissue (Fig. 10). Because the 
Figure 9. Northern blot analysis of myr 1 mRNA in adult and neo- 
natal  rat tissues.  Poly(A)  + RNA was purified from adult (A) and 
neonatal rat tissues (B). Northern blots (1 #g Poly(A)  + RNA/lane) 
were hybridized  with the PCR fragment 22/16-1 as described  in 
Materials and Methods. The respective tissues are indicated above 
each lane. Size standards are in kilobases. 
Figure 10. Tissue distribution and differential expression of myr 1 
a-c. Equal amounts of  protein from different tissues were separated 
on SDS-PAGE and immunoblotted  with the antibody "I'fi  30 fol- 
lowed by a secondary antibody coupled  to alkaline phosphatase. 
The respective positions for myr la, myr lb, and myr lc are indi- 
cated.  Molecular weight standards in kDa are shown on the left. 
Tissues are indicated on top of each lane, with El9 brain denoting 
embryonic day 19 rat brain. 
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molecular mass of this band coincided with the predicted 
molecular weight for myr lc and because we detected no ad- 
ditional bands by immunoblotting, we refer to it as myr lc. 
Myr 1 a-c were differentially expressed in the various tested 
tissues.  Myr  la  was  most prominently expressed in  em- 
bryonic brain tissue (see for comparison also Fig. 3) and in 
adult tissues of the various brain regions and in testis. Myr 
lb and lc were most prominently expressed in lung and liver. 
Lower levels of myr lb and lc were observed in many other 
tissues including intestine (Fig.  10, and data not shown). 
The identical three protein bands were also recognized by 
the myosin-I consensus antibody G-371 as demonstrated by 
probing proteins specifically immunoprecipitated with the 
myr 1 specific antibody Tii 2. 
Great care was taken to avoid any proteolysis by directly 
placing the excised tissues in 1% SDS and boiling of the tis- 
sues. Furthermore, after longer storage protein degradation 
could indeed be observed, but always yielded breakdown 
products with substantially lower apparent molecular masses 
(see, e.g.,  Figs.  2 and  11). A tissue dependent differential 
myr  1  breakdown  also  seemed  extremely unlikely.  And 
finally, the identification of three closely spaced bands was 
in excellent agreement with the identification of three myr 1 
splice forms by eDNA cloning techniques. However, to even 
further verify that the bands we refer to as myr lb and myr 
lc behaved like myr la, we tested whether these proteins are 
selectively released by ATP and  whether they bind in an 
ATP-dependent manner to F-actin. As shown in Fig.  11 a, 
myr lb and lc were selectively released by ATP from lung 
tissue particulate fractions. We partially purified myr lb and 
lc from rat liver as described in Materials and Methods and 
tested  the  two  proteins  for  nucleotide-dependent F-actin 
binding. Both myr lb and myr lc cosedimented with F-actin 
in the absence of ATP, but not in the presence of ATP (Fig. 
11 b), demonstrating nueleotide-dependent  binding to F-actin. 
Figure 11. (a) ATP-dependent  extraction of myr lb and lc. Rat lung 
tissue was homogenized (lane 1 ) and extracted in the absence (lane 
2), or presence (lane 3) of ATP as described under Materials and 
Methods. Proteins were separated on SDS-PAGE  and immunoblot- 
ted with the Tti 30 antibody. Myr Ib and lc recognized by the Tfi 
30 antibody are selectively extracted by ATP and are marked. (b) 
Nucleotide-dependent binding of myr lb and lc from rat liver to 
F-actin. The myr lb, lc protein doublet recognized by the Tti 2 anti- 
body in rat liver was partially purified as described in Materials and 
Methods and incubated in the absence or presence (+) of actin 
(5 #M) and ATP (2 mM).  The F-actin binding was assayed by 
cosedimentation with F-actin. Supernatants (s) and pellets (p) were 
analyzed for myr lb and lc proteins by immunoblotting with the Tfi 
2 antibody. Molecular weight standard in kD is shown on the right. 
Breakdown products of myr lb and lc are also apparent. Myr lb 
and lc are marked on the left. 
Discussion 
In the present study we describe the identification, charac- 
terization and cloning of a mammalian myosin-I, myr la-c, 
which exhibits a remarkable similarity to the brush border 
myosin-I. The identification was based on an antibody raised 
against a synthetic peptide with a highly conserved sequence 
specific for myosin-Is, however, sufficiently different from 
conventional myosins. The sequence spans the myosin-I se- 
quence analogous to the flexible, exposed region of the SH2- 
SH1 reactive thiols of  conventional myosins. The antibody as 
described  in  this  report might be of general  use  for the 
identification of novel myosin-Is (BElaler, M.,  1990. Z  Cell 
Biol.  111:167a; Behrmann, T., C. Ruppert, R. Kroschewski, 
S.  Kieferle and  M.  B~hler.  1992.  Fur.  J.  Cell  Biol.  57: 
8 (Suppl. 36). Because modification of SH2 and SH1 reactive 
thiols in conventional myosins interferes with motor function 
(for review 49, 65), the antibody might also be of value for 
studying myosin-I motor function. 
Amino acid sequence comparison revealed that rat myr 1 
shares a remarkable homology with both the head and tail 
domains  of bovine and  chicken  brush  border  myosin-Is. 
However, as opposed to brush border myosin-I which is ex- 
pressed predominantly in intestine (19, 32), myr 1 was ex- 
pressed in a  variety of neonatal and adult tissues and was 
Ruppert et al. Mammalian Myosin-I  1401 barely detectable in adult intestine. Myr 1 was most abun- 
dant in lung, liver and brain and the expression pattern was 
not correlated with the abundance of microvilli. Further- 
more, myr 1 was found to exist in at least three isoforms 
which most likely arise by differential splicing. 
The existence of  a brush border myosin-I multigene family 
had been suggested based on Southern blot data obtained 
with a bovine brush border myosin-I probe (28). In addition, 
antibodies raised against brush border myosin-I were found 
to react with a 135-kD calmodulin-binding protein from rat 
fetal brush borders (56), a  130-kD protein from mouse F9 
teratocarcinoma cells (15), a 130- and a 140-kD protein from 
human intestinal cell lines (52) and a  150-kD protein from 
mouse brain (45). The relationships of these immunogens to 
myr 1 remain to be determined. Very recently, the purifica- 
tion of a  ll6-kD myosin-I from bovine adrenal gland and 
brain with similarities to brush border myosin-I has been de- 
scribed (4). However, the reported bovine 116-kD myosin-I 
peptide sequences make it very unlikely that this protein is 
identical to rat myr 1. The mentioned observations raise the 
possibility that there exists a larger family of brush border 
type myosin-Is. 
Motor activity, calmodulin-binding and lipid-binding have 
been analyzed in some detail for brush border myosin-I (I1, 
26, 48, 61).  Based on the sequence similarity of myr 1 with 
brush border myosin-I, it can be postulated that myr 1 shares 
many properties with brush border myosin-I. We have dem- 
onstrated that myr 1 is extracted from tissue homogenates by 
ATP, that it binds in a nucleotide-dependent  manner to F-actin 
and that it binds calmodulin. It remains to be shown whether 
myr 1 exhibits actin-activated ATPase activity which is reg- 
ulated by Ca2+/calmodulin  and whether myr 1 binds to neg- 
atively charged phospholipids and membranes. 
To address the functions of brush border myosin-I, Cou- 
drier et al. (13) expressed the tail domain of chicken brush 
border myosin-I in cell lines. Interestingly, the brush border 
myosin-I tail localized in cells without microvilli to orga- 
nelles and disrupted the Golgi-complex suggesting a role in 
membrane trafficking.  It will  be interesting to determine 
whether overexpression of the brush border myosin-I tail in- 
terferes with the function of myr 1. 
We have demonstrated that myr la can bind calmodulin 
and therefore myr  1 function is likely to be regulated by 
CaE+/calmodulin.  Three repeats of a Ca2+-independent  cal- 
modulin binding motif (IQ-motif, 7) were detected in myr 
1. Overlapping with the third repeat was a second putative 
calmodulin/light chain binding motif, the 29 residue motif. 
Myr 1 splice forms differ in their numbers of the 29 residue 
motif in the regulatory domain. This motif shares a consid- 
erable homology with a 29 residue insert at the analogous 
position in chicken brush border myosin-I (23).  Interest- 
ingly, a synthetic peptide of the brush border myosin-I insert 
sequence has been demonstrated to bind calmodulin (23). 
Therefore, the variable numbers of 29 residue repeats in myr 
1 might lead to different numbers of calmodulin/light chain 
binding sites. The 29 residue motif does not fit well into the 
IQ-motif which binds calmodulin in the absence of Ca  2+. 
However, the 29 residue motif does also not conform to the 
highly basic amphipathic or-helix motif for calcium-depen- 
dent calmodulin binding sites (50). It contains a high number 
of basic and hydrophobic residues which are predicted to 
form a helical secondary structure. Further studies are needed 
to clarify whether this motif  is a calmodulin/light chain bind- 
ing site. Whatever the precise role of the 29 residue motif 
will turn out to be, it seems likely that this motif serves a 
regulatory function. Several calmodulin-binding sequences 
have also been shown to bind to phospholipid vesicles (16, 
61) making the calmodulin/light chain binding motifs pos- 
sible mediators between motor activity and cargo interaction. 
Myr 1 is the first myosin-I motor molecule with a wide- 
spread distribution in neonatal and adult tissues. Individual 
members of myr 1 exhibited a tissue and developmentally 
regulated  expression.  Myr  la  was  most  prominently ex- 
pressed in the developing nervous tissue. Furthermore, upon 
subceUular fractionation of fetal rat brain, myr la was found 
to be enriched in purified growth cone particles. Although 
the relative enrichment was lower than for GAP-43, an ax- 
onal growth cone marker protein (21, 44), this result does 
provide evidence for the presence of myr la in growth cones. 
Myr la might possibly be associated with a membranous 
structure since purified growth cone particles are enriched 
in  membranous  structures  (53).  However,  in  situ  im- 
munolocalization studies are required to determine its exact 
localization. 
Myr lb and lc were predominantly expressed in adult non- 
neuronal tissues, e.g., lung and liver. The differential expres- 
sion of the myr 1 splice forms could provide a specific means 
of adaptation to a particular cellular environment since they 
differ only in  their  numbers  of putative  calmodulin/light 
chain binding sites. 
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